Ro5 vs Vaxess Technologies
Ro5
Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph
12 employees · est. 2018 · London, United Kingdom
Vaxess Technologies
Forging a path to more convenient, self-empowered, and accessible healthcare
61 employees · est. 2012 · Boston, United States
Vaxess Technologies is the older company (2018 vs 2012); Vaxess Technologies is the larger of the two.
Side-by-Side Comparison
| Metric | Ro5 | Vaxess Technologies |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2012 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Boston, United States |
| Employees | ||
| Employees | 12 | 61 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Venture round |
| Total Funding | ||
| Total Funding | Not tracked yet | $83.24M |
| Funding Rounds | ||
| Funding Rounds | 3 | 15 |
| Services | ||
| Services | Development of innovative medicines targeting core aging mechanisms, Clinical-stage drug trials, AI-enabled R&D for drug discovery and development, Adaptive clinical trial design | Development of microarray patch platforms, Delivery of next-gen therapies using MAP, Temperature stable drug delivery solutions |
| Target Customers | ||
| Target Customers | Investors seeking high returns in biopharma, Healthcare providers focusing on longevity and preventive care, Institutions looking for innovative aging treatments, Pharmaceutical companies interested in strategic collaborations | Patients seeking convenient healthcare solutions, Individuals needing temperature stable treatments, Healthcare providers looking for innovative delivery methods |
| Taxonomy | ||
| Taxonomy | AI In Drug DiscoveryDe Novo Drug DiscoveryADMET AnalysisKnowledge GraphsDigital Transformation In PharmaR&D Software Solutions +9 | Microarray Patch TechnologySustained Release VaccinesNext-Generation TherapiesDose Delivery ControlNon-Refrigerated DeliveryLow-Resource Settings Delivery +9 |
| Website | ||
| Website | Ro5.ai | vaxess.com |
About Ro5
Ro5, founded in 2018 and headquartered in the United Kingdom, is making significant strides in the intersection of AI, Biotechnology, and Pharmaceutical industries. With its compelling slogan, "Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.", Ro5 positions itself as a pioneering force...
About Vaxess Technologies
Vaxess Technologies, established in 2012, is positioning itself as a transformative force in the Biotechnology and Health Care industries. The company is dedicated to making healthcare more convenient, self-empowered, and accessible through its innovative delivery platform. The platform features a...
Also comparing in this category
Comparing more than these two?
Get Ro5, Vaxess Technologies and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Ro5 compare?
A PDF of Ro5 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Ro5 with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ro5 on 11 Mar 2026, and Vaxess Technologies on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
